Epirubicin and Thalidomide in Treating Patients With Liver Cancer
Clinical trial NCT00058487 · COMPLETED
Trial details
- NCT number
- NCT00058487
- Sponsor
- Dana-Farber Cancer Institute
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2001-12-01
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.